Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Orthopedic Bone Cement and Casting Materials Pipeline Market Report Overview

Bone cement and casting materials are used to fix bone fractures or as a complement to other devices in procedures such as joint reconstruction and trauma fixation. The Orthopedic Bone Cement and Casting Materials pipeline market research report provides comprehensive information about the Orthopedic Bone Cement and Casting Materials pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        Global

·        The US

·        China

·        Europe

·        Canada

Key Segments ·        Bone Cement

·        Casting Materials

·        Antibiotic Bone Cement

·        Nonantibiotic Bone Cement

Key Regulatory Paths ·        510(k)

·        NMPA

·        CE

·        MDL

·        BOPA

Leading Companies ·        Biofix Medical Technologies

·        Bone-Rad Therapeutics, Inc.

·        Chinese Academy of Sciences

·        Dalhousie University

·        DePuy Synthes Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Orthopedic Bone Cement and Casting Materials Pipeline Market Segmentation by Segments

Some of the key segments in the Orthopedic Bone Cement and Casting Materials market are bone cement, casting materials, antibiotic bone cement, and nonantibiotic bone cement. As of November 2023, bone cement has the highest number of pipeline products.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Segments, 2023 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market

Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market Segmentation by Territories

Some of the key territories in the Orthopedic Bone Cement and Casting Materials market are the US, China, Europe, Global, and Canada among others. As of November 2023, the global segment has the highest number of pipeline products.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Territories, 2023 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market

Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Orthopedic Bone Cement and Casting Materials pipeline market are 510(k), NMPA, CE, MDL, and BOPA. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market

Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market – Competitive Landscape

Some of the key companies in the Orthopedic Bone Cement and Casting Materials pipeline market are:

  • Biofix Medical Technologies
  • Bone-Rad Therapeutics, Inc.
  • Chinese Academy of Sciences
  • Dalhousie University
  • DePuy Synthes Inc

Chinese Academy of Sciences (CAS): It is an academic institution that provides appraisal and advisory services on issues arising from the national economy, social development, and science and technology progress. It offers services such as experimental development, education and training, basic and applied research, and science and technology advice. The institute conducts research in the areas of automation, botany, chemistry, electronics, science, microbiology, geology, geophysics, mathematics, and nanoscience and technology. CAS also conducts research in areas such as semiconductors, psychology, systems sciences, theoretical physics, natural resources, mechanics, and zoology, among others. It promotes strategic partnerships with first-rate research institutions, international science organizations, and multinational research and development corporations. The institute operates in Guangzhou, Kunming, Lanzhou, Beijing, Changchun, Chengdu, Nanjing, Shenyang, Wuhan, Shanghai, Xi’an, and Xinjiang, China. CAS is headquartered in Beijing, China.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Companies, 2023

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Orthopedic Bone Cement and Casting Materials Pipeline Market Segments Outlook

  • Bone Cement
  • Casting Materials
  • Antibiotic Bone Cement
  • Nonantibiotic Bone Cement

Orthopedic Bone Cement and Casting Materials Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Global
  • Canada

Orthopedic Bone Cement and Casting Materials Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE
  • MDL
  • BOPA

Scope

This report provides:

  • Extensive coverage of the Orthopedic Bone Cement and Casting Materials under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Orthopedic Bone Cement and Casting Materials under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Biofix Medical Technologies
Bone-Rad Therapeutics, Inc.
Chinese Academy of Sciences
Dalhousie University
DePuy Synthes Inc
Exactech Inc
Graftys SA
Hyalex Orthopaedics Inc
Inossia AB
Maxigen Biotech Inc
Medical Compression Systems (DBN) Ltd
MediPrint
Moroxite F AB
National University of Science and Technology MiSiS
Next Casting Technologies
Onbone Oy
OSARTIS GmbH
Osseon Therapeutics Inc
Ozics AG
Queen Mary University of London
Queen's University Belfast
Setbone Medical Ltd
Shenzhen Healthemes Biotechnology Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stryker Corp
University of Limerick
University of Missouri
Zimmer Biomet Holdings Inc
Zimmer GmbH

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Orthopedic Bone Cement and Casting Materials Overview 10

3 Products under Development 11

3.1 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development 11

3.2 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment 12

3.3 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory 13

3.4 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path 14

3.5 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date 15

3.6 Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials 16

4 Orthopedic Bone Cement and Casting Materials – Pipeline Products under Development by Companies 17

4.1 Orthopedic Bone Cement and Casting Materials Companies – Pipeline Products by Stage of Development 17

4.2 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development 19

5 Orthopedic Bone Cement and Casting Materials Companies and Product Overview 20

5.1 Biofix Medical Technologies Company Overview 20

5.1.1 Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Bone-Rad Therapeutics, Inc. Company Overview 21

5.2.1 Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Chinese Academy of Sciences Company Overview 22

5.3.1 Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 Dalhousie University Company Overview 23

5.4.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 DePuy Synthes Inc Company Overview 24

5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 Exactech Inc Company Overview 25

5.6.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Graftys SA Company Overview 26

5.7.1 Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Hyalex Orthopaedics Inc Company Overview 28

5.8.1 Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Inossia AB Company Overview 29

5.9.1 Inossia AB Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Maxigen Biotech Inc Company Overview 32

5.10.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Medical Compression Systems (DBN) Ltd Company Overview 33

5.11.1 Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 MediPrint Company Overview 34

5.12.1 MediPrint Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Moroxite F AB Company Overview 35

5.13.1 Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview 35

5.14 National University of Science and Technology MiSiS Company Overview 38

5.14.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Next Casting Technologies Company Overview 39

5.15.1 Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview 39

5.16 Onbone Oy Company Overview 40

5.16.1 Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 40

5.17 OSARTIS GmbH Company Overview 41

5.17.1 OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview 41

5.18 Osseon Therapeutics Inc Company Overview 42

5.18.1 Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Ozics AG Company Overview 43

5.19.1 Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 Queen Mary University of London Company Overview 44

5.20.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 Queen’s University Belfast Company Overview 45

5.21.1 Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 Setbone Medical Ltd Company Overview 46

5.22.1 Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Shenzhen Healthemes Biotechnology Co Ltd Company Overview 47

5.23.1 Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 50

5.24.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 Stryker Corp Company Overview 53

5.25.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 53

5.26 University of Limerick Company Overview 54

5.26.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 54

5.27 University of Missouri Company Overview 56

5.27.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 56

5.28 Zimmer Biomet Holdings Inc Company Overview 57

5.28.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.29 Zimmer GmbH Company Overview 58

5.29.1 Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview 58

6 Orthopedic Bone Cement and Casting Materials- Recent Developments 59

6.1 Oct 30, 2023: Japan Medical Dynamic Marketing Announces Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 2024 59

6.2 Oct 23, 2023: Jan Gurander Proposed as New Chairman of Essity 60

6.3 Oct 09, 2023: Stryker to Host Investor Day 60

6.4 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 60

6.5 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 61

6.6 Sep 25, 2023: OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting 61

6.7 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board 61

6.8 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business 62

6.9 Sep 14, 2023: Smith & Nephew Announces Board Changes 62

6.10 Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team 63

6.11 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 64

6.12 Aug 22, 2023: Zimmer Biomet Announces Leadership Transition 64

6.13 Aug 10, 2023: Essity Hires Sandra Aberg as Vice President and Head of Investor Relations 65

6.14 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 65

6.15 Jul 28, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2024 65

6.16 Jun 13, 2023: AAP Implantate Executive Board proposes in the invitation to the Annual General Meeting various capital measures for resolution 66

6.17 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 67

6.18 May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report 67

6.19 Apr 28, 2023: Japan Medical Dynamic Marketing announces summary of consolidated financial results for the fiscal year ended March 2023 68

6.20 Apr 27, 2023: Essity releases interim report for Q1 2023 69

6.21 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 70

6.22 Apr 12, 2023: Medtronic has a layoff in California 73

6.23 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 73

6.24 Mar 31, 2023: OrthoPediatrics Leading Sponsorship at Annual EPOS Meeting 73

6.25 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 73

6.26 Mar 22, 2023: Vitrolife Notice to attend the Annual General Meeting 74

6.27 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 74

6.28 Mar 10, 2023: Ossur Announces Results of the Annual General Meeting 74

6.29 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 75

6.30 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 75

6.31 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 75

6.32 Feb 17, 2023: Ossur Announces Annual General Meeting 76

6.33 Jan 31, 2023: Ossur Announces Annual Report 2022 77

6.34 Jan 31, 2023: Ossur Announces Interim Report Q4 & FY 2022 77

6.35 Jan 31, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 2023 78

6.36 Jan 17, 2023: Ossur Announces Conference Call Tuesday 31 January at 9:00 CET 78

6.37 Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility 79

6.38 Dec 12, 2022: Change to Essity’s Executive Management Team 81

6.39 Nov 23, 2022: Medtronic Reports Quarterly Earnings 81

6.40 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 81

7 Appendix 88

7.1 Methodology 88

7.2 About GlobalData 91

7.3 Contact Us 91

7.4 Disclaimer 91

Table

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development 11

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment 12

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory 13

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path 14

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date 15

Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials 16

Orthopedic Bone Cement and Casting Materials Companies – Pipeline Products by Stage of Development 17

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development 19

Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 20

Injectable Glass Ionomer Cement – Product Status 20

Injectable Glass Ionomer Cement – Product Description 20

Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Spine-Rad Brachytherapy Bone Cement – Product Status 21

Spine-Rad Brachytherapy Bone Cement – Product Description 21

Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview 22

BG Bone Cement – Product Status 22

BG Bone Cement – Product Description 22

Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 23

Minimally Invasive System – Bone Augmentation – Product Status 23

Minimally Invasive System – Bone Augmentation – Product Description 23

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Statin Eluting Bone Cements – Product Status 24

Statin Eluting Bone Cements – Product Description 24

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Cemex Bone Cement – Product Status 25

Cemex Bone Cement – Product Description 25

Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 26

GRFT-M03 – Product Status 26

GRFT-M03 – Product Description 26

GRFT-M05 – Product Status 27

GRFT-M05 – Product Description 27

Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Hyalex Bone Cement – Product Status 28

Hyalex Bone Cement – Product Description 28

Inossia AB Pipeline Products & Ongoing Clinical Trials Overview 29

V-Flex – Product Status 29

V-Flex – Product Description 29

Inossia AB – Ongoing Clinical Trials Overview 30

V-Flex – A Multicentre, Single-blind, RCT to Document the Safety and Efficacy of the Use of a Bone Cement With or Without Inossia Cement Softener for Patients With Vertebral Compression Fractures 31

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 32

MaxCement – Product Status 32

MaxCement – Product Description 32

Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

ActiveCast – Product Status 33

ActiveCast – Product Description 33

MediPrint Pipeline Products & Ongoing Clinical Trials Overview 34

NovaCast – Product Status 34

NovaCast – Product Description 34

Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview 35

Fracture Fixation Device – Product Status 35

Fracture Fixation Device – Product Description 35

Moroxite F AB – Ongoing Clinical Trials Overview 36

Fracture Fixation Device – An Open-labelled Pilot Study to Evaluate Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate for Trochanteric Femur Fracture 37

National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 38

Ceramic Composite Polymer – Product Status 38

Ceramic Composite Polymer – Product Description 38

Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview 39

Next Generation SmartCast – Product Status 39

Next Generation SmartCast – Product Description 39

Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 40

BIOCEMENT – Product Status 40

BIOCEMENT – Product Description 40

OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview 41

Ag Cement – Product Status 41

Ag Cement – Product Description 41

Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Monetite – Based Injectable Orthopaedic Cement – Product Status 42

Monetite – Based Injectable Orthopaedic Cement – Product Description 42

Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 43

CompO6 Reinforced Bone Composite – Osteoporotic Fractures – Product Status 43

CompO6 Reinforced Bone Composite – Osteoporotic Fractures – Product Description 43

Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview 44

Calcium Phosphate Bone Cement – Product Status 44

Calcium Phosphate Bone Cement – Product Description 44

Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview 45

Spinal Cement – Product Status 45

Spinal Cement – Product Description 45

Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

ReadySet Bone Cement – Product Status 46

ReadySet Bone Cement – Product Description 46

Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Shenzhen Bone Cement – Product Status 47

Shenzhen Bone Cement – Product Description 47

Shenzhen Healthemes Biotechnology Co Ltd – Ongoing Clinical Trials Overview 48

Shenzhen Bone Cement – Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body 49

Shenzhen Bone Cement – Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body 49

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 50

BioCaS – Product Status 50

BioCaS – Product Description 50

Bone Cement – Product Status 51

Bone Cement – Product Description 51

Calcium Phosphate Bone Cement – Product Status 51

Calcium Phosphate Bone Cement – Product Description 52

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 53

Cortoss – Cranial Defects – Product Status 53

Cortoss – Cranial Defects – Product Description 53

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 54

Bioactive Adhesive Cement – Product Status 54

Bioactive Adhesive Cement – Product Description 54

Dual Calcium Phosphate Paste System – Product Status 55

Dual Calcium Phosphate Paste System – Product Description 55

Heracap – Product Status 55

Heracap – Product Description 55

University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 56

Bone Cement – Product Status 56

Bone Cement – Product Description 56

Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Cobalt Stage One Acrylic Spacer Cement – Product Status 57

Cobalt Stage One Acrylic Spacer Cement – Product Description 57

Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview 58

Resurgent – Product Status 58

Resurgent – Product Description 58

Glossary 90

Figures

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development 11

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment 12

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory 13

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path 14

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date 15

Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials 16

Frequently asked questions

Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.